Guidance on management of drugs requiring monitoring during Covid-19

The SPS has issued guidance on drug monitoring and factors to consider in mornitoring, for various medicines including azathioprine, leflunomide, mercatopurine, methotrexate, sulfasalazine, hydroxychloroquine, ciclosporin, penicillamine and warfarin.

Specialist Pharmacy Service